Sixteen tumor samples from mice without FcγR blockade (1 treated with control IgG, 6 with G6.31.2a alone, 3 with 4D5.2a alone, 5 with the combination, and 1 with TG-VHS) were combined into one group, and 14 tumor samples from mice with FcγR blockade (2 treated with G6.31.2a alone, 2 with 4D5.2a alone, 4 with the combination, and 6 with TG-VHS) were combined into another group. Here, FCGR2A is linked to neoplasm.